Literature DB >> 19432674

Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma.

Natalia Golardi1, Mario R Velasco, M Tarek Elghetany.   

Abstract

Described herein is an unusual case of mantle cell lymphoma (MCL) histologically mimicking marginal zone lymphoma (MZL). An 83-year-old man presented with multiple adenopathies and a hilar mass encroaching on the right lung. A transbronchial biopsy showed small blue cells suspicious for small cell carcinoma. On further analysis the cells were predominantly small cleaved and CD20 positive, suggesting follicular lymphoma, grade 2. An axillary lymph node biopsy showed germinal centers surrounded by monocytoid B cells. Flow cytometry was negative for CD5 and CD23 and the diagnosis of MZL was considered. Because of the aggressive clinical behavior, including extensive necrosis on imaging studies, immunohistochemistry for cyclin D-1 was performed and was positive. Bone marrow was extensively involved and it showed t(11;14), in addition to other complex cytogenetic abnormalities. Differentiating MCL from MZL has prognostic and therapeutic implications, particularly when considering the potential role of targeted therapy and cell cycle modulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432674     DOI: 10.1111/j.1440-1827.2009.02372.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Eman Al Mussaed; Hassan Aljasem; Sultan Alotaibi; Hatem Elghezal
Journal:  Case Rep Hematol       Date:  2015-08-10

2.  Mantle cell lymphoma with features of marginal-zone lymphoma.

Authors:  Ulla Randen; Olav Erich Yri; Anne Tierens; Sverre Heim; Klaus Beiske; Jan Delabie
Journal:  J Hematop       Date:  2011-03-02       Impact factor: 0.196

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.